Mutual Advisors LLC Reduces Stock Position in ARK Genomic Revolution ETF (BATS:ARKG)

Mutual Advisors LLC trimmed its holdings in shares of ARK Genomic Revolution ETF (BATS:ARKG) by 5.2% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 38,376 shares of the company’s stock after selling 2,084 shares during the period. Mutual Advisors LLC owned 0.07% of ARK Genomic Revolution ETF worth $931,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently bought and sold shares of ARKG. JPMorgan Chase & Co. grew its position in shares of ARK Genomic Revolution ETF by 31.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 2,955,279 shares of the company’s stock valued at $75,655,000 after buying an additional 698,701 shares during the last quarter. Atom Investors LP boosted its stake in ARK Genomic Revolution ETF by 15.2% in the third quarter. Atom Investors LP now owns 49,131 shares of the company’s stock valued at $1,258,000 after acquiring an additional 6,496 shares in the last quarter. Barclays PLC grew its holdings in shares of ARK Genomic Revolution ETF by 252.7% during the third quarter. Barclays PLC now owns 285,108 shares of the company’s stock worth $7,299,000 after purchasing an additional 204,283 shares during the last quarter. Elmwood Wealth Management Inc. lifted its holdings in shares of ARK Genomic Revolution ETF by 39.7% in the 3rd quarter. Elmwood Wealth Management Inc. now owns 57,766 shares of the company’s stock valued at $1,479,000 after purchasing an additional 16,412 shares during the last quarter. Finally, National Bank of Canada FI lifted its holdings in shares of ARK Genomic Revolution ETF by 28.4% in the 3rd quarter. National Bank of Canada FI now owns 4,155 shares of the company’s stock valued at $106,000 after purchasing an additional 920 shares during the last quarter.

ARK Genomic Revolution ETF Trading Up 14.7 %

BATS:ARKG opened at $27.09 on Friday. The stock’s 50-day moving average price is $24.89 and its 200 day moving average price is $25.14.

ARK Genomic Revolution ETF Company Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.